Veronika Sharp, MD
Rheumatology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 3 carriers
- Offices
- 2
Offices
2 locations · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
14 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sharp’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A88610 · Current
Licensed to practise in California · since 2004 · expires 2028-01-31 · University of Pecs Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$21,495
Medicare paid this office $21,495 for 130 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 110 | $14,966 | $73 |
| New patient visit (45+ min) | 16 | $1,462 | $91 |
| Aspiration and/or injection of fluid from large joint | 19 | $1,267 | $49 |
| Long return visit (40+ min) | 11 | $1,078 | $98 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 20 | $301 | $15 |
Who their Medicare patients are
130 Original Medicare patients in 2024. Average age 70 · Under 65 17% · 85 and older 9% · Women 75% · Also on Medicaid 82% · Health risk score 1.97. Sicker patients than 9 in 10 peers; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 75% · Diabetes 37% · Chronic kidney disease 31% · Heart failure 21% · Coronary heart disease 20% · Depression 16% · Atrial fibrillation 15% · Cancer 13% · Stroke 11%.
The office billed $216,901, Medicare allowed $32,088 and paid $21,495; for 304 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 130 | 304 | 70 | 1.97 | $216,901 | $21,495 |
| 2023 | 136 | 270 | 71 | 1.73 | $201,244 | $22,322 |
| 2022 | 147 | 336 | 70 | 1.40 | $215,515 | $22,885 |
| 2021 | 146 | 260 | 69 | 1.66 | $149,436 | $17,618 |
| 2020 | 174 | 352 | 69 | 1.83 | $186,219 | $19,216 |
| 2019 | 219 | 495 | 69 | 1.67 | $312,845 | $29,559 |
| 2018 | 207 | 489 | 68 | 1.55 | $309,425 | $28,585 |
| 2017 | 201 | 542 | 67 | 1.53 | $279,651 | $28,246 |
| 2016 | 132 | 295 | 67 | 1.41 | $118,367 | $15,642 |
| 2014 | 127 | 295 | 69 | 1.20 | $70,374 | $10,771 |
| 2013 | 155 | 490 | 67 | 1.22 | $101,681 | $17,366 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 102 | $13,467 | $77 |
| Long return visit (40+ min) | 20 | $2,436 | $122 |
| New patient visit (45+ min) | 18 | $2,054 | $114 |
2022: 6 services
| Return visit (30+ min) | 115 | $13,082 | $72 |
| Long return visit (40+ min) | 17 | $2,427 | $121 |
| Telephone medical discussion with physician, 21-30 minutes | 22 | $1,453 | $66 |
| Telephone medical discussion with physician, 11-20 minutes | 26 | $1,217 | $42 |
| Short return visit (20+ min) | 21 | $1,176 | $53 |
| Aspiration and/or injection of fluid from large joint | 17 | $964 | $40 |
2021: 6 services
| Return visit (30+ min) | 70 | $6,527 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $2,738 | $78 |
| Telephone medical discussion with physician, 21-30 minutes | 38 | $2,082 | $51 |
| Short return visit (20+ min) | 37 | $1,771 | $47 |
| Aspiration and/or injection of fluid from large joint | 18 | $1,016 | $42 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $603 | $35 |
2020: 6 services
| Telephone medical discussion with physician, 21-30 minutes | 81 | $6,759 | $63 |
| Return visit (30+ min) | 86 | $5,566 | $50 |
| Telephone medical discussion with physician, 11-20 minutes | 26 | $1,188 | $41 |
| Aspiration and/or injection of fluid from large joint | 17 | $1,089 | $44 |
| Short return visit (20+ min) | 23 | $864 | $33 |
| Telephone medical discussion with physician, 5-10 minutes | 14 | $300 | $21 |
2019: 5 services
| Return visit (30+ min) | 166 | $17,905 | $60 |
| Aspiration and/or injection of fluid from large joint | 38 | $2,591 | $43 |
| Long return visit (40+ min) | 18 | $2,032 | $92 |
| New patient visit (45+ min) | 23 | $1,905 | $83 |
| New patient visit (30+ min) | 12 | $482 | $40 |
2018: 7 services
| Return visit (30+ min) | 145 | $16,145 | $60 |
| New patient visit (45+ min) | 47 | $4,088 | $87 |
| Aspiration and/or injection of fluid from large joint | 43 | $2,511 | $39 |
| Long return visit (40+ min) | 18 | $1,895 | $100 |
| Short return visit (20+ min) | 20 | $829 | $35 |
| New patient visit (30+ min) | 17 | $748 | $44 |
| Complete ultrasound scan of joint | 12 | $345 | $29 |
2017: 6 services
| Return visit (30+ min) | 132 | $17,233 | $62 |
| Short return visit (20+ min) | 72 | $2,799 | $31 |
| Aspiration and/or injection of fluid from large joint | 40 | $2,218 | $37 |
| New patient visit (45+ min) | 14 | $1,386 | $99 |
| Complete ultrasound scan of joint | 26 | $833 | $27 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 13 | $332 | $21 |
2016: 4 services
| Return visit (30+ min) | 94 | $9,491 | $67 |
| Short return visit (20+ min) | 52 | $2,780 | $45 |
| Aspiration and/or injection of fluid from large joint | 22 | $1,272 | $32 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 11 | $243 | $22 |
2014: 4 services
| Short return visit (20+ min) | 98 | $4,544 | $32 |
| Aspiration and/or injection of fluid from large joint | 33 | $1,637 | $30 |
| Return visit (30+ min) | 25 | $1,312 | $44 |
| New patient visit (30+ min) | 15 | $958 | $64 |
2013: 3 services
| Short return visit (20+ min) | 132 | $10,664 | $36 |
| Aspiration and/or injection of fluid from large joint | 46 | $3,776 | $30 |
| New patient visit (30+ min) | 18 | $980 | $54 |
Medicaid work
$11,032 in 2024
Medicaid paid $11,032 for 2,743 billed services this clinician did in 2024, up to 94 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 713 | $9,818 |
| Long return visit (40+ min) | 19 | $611 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 36 | $588 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 48 | $15 |
| Pain severity quantified; pain present (COA) (ONC) | 44 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 12 | $0 |
| Medication list documented in medical record (COA) | 546 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 462 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 159 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 33 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 483 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 176 | $0 |
| 2024 | 2,743 | 13 | 94 | $11,032 |
| 2023 | 937 | 7 | 73 | $5,652 |
| 2022 | 426 | 3 | 55 | $5,119 |
| 2021 | 430 | 4 | 55 | $2,147 |
| 2020 | 289 | 1 | 53 | $2,373 |
| 2019 | 897 | 7 | 83 | $4,355 |
| 2018 | 861 | 5 | 77 | $5,623 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 643 | $5,169 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 13 | $483 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 36 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 63 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 41 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 125 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 16 | $0 |
2022
| Return visit (30+ min) | 287 | $3,615 |
| Short return visit (20+ min) | 125 | $1,027 |
| Service | 14 | $477 |
2021
| Return visit (30+ min) | 251 | $1,479 |
| Short return visit (20+ min) | 99 | $375 |
| Short return visit | 68 | $294 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 12 | $0 |
2020
| Return visit (30+ min) | 289 | $2,373 |
2019
| Return visit (30+ min) | 739 | $3,358 |
| Arthrocentesis and injection of knee joint | 50 | $289 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 27 | $229 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 13 | $181 |
| New patient visit (45+ min) | 16 | $179 |
| Creatinine; blood | 25 | $69 |
| Long return visit (40+ min) | 27 | $49 |
2018
| Return visit (30+ min) | 720 | $3,982 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 78 | $1,427 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 13 | $115 |
| Arthrocentesis and injection of knee joint | 34 | $99 |
| Short return visit (20+ min) | 16 | $0 |
Drugs they prescribed that Part D paid
$2,899,145
Pharmacies billed $2,899,145 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (50 of 1,367) in 2024. Above the middle of the specialty; the typical rheumatology clinician is at 3%.
863 generic and 504 brand-name prescriptions · $2,899,145 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Enbrel Sureclick | 83 | $559,460 | $6,740 |
| Humira | 66 | $440,674 | $6,677 |
| Humira | 45 | $290,505 | $6,456 |
| Xeljanz | 45 | $268,735 | $5,972 |
| Humira(Cf) | 18 | $176,949 | $9,831 |
See all 33 drugs
| Enbrel Sureclick | 83 | $559,460 | $6,740 |
| Humira | 66 | $440,674 | $6,677 |
| Humira | 45 | $290,505 | $6,456 |
| Xeljanz | 45 | $268,735 | $5,972 |
| Humira(Cf) | 18 | $176,949 | $9,831 |
| Orencia Clickject | 29 | $147,830 | $5,098 |
| Xeljanz Xr | 24 | $131,515 | $5,480 |
| Simponi | 21 | $117,351 | $5,588 |
| Cosentyx Sensoready | 12 | $104,642 | $8,720 |
| Enbrel Mini | 14 | $91,939 | $6,567 |
| Enbrel | 11 | $85,673 | $7,788 |
| Otezla | 13 | $62,786 | $4,830 |
| Mitigare | 17 | $10,446 | $614 |
| Mycophenolate Mofetil | 30 | $8,259 | $275 |
| Colchicine | 60 | $7,175 | $120 |
| Methotrexate | 96 | $2,756 | $29 |
| Febuxostat | 47 | $2,583 | $55 |
| Leflunomide | 30 | $2,335 | $78 |
| Hydroxychloroquine Sulfate | 49 | $2,148 | $44 |
| Sulfasalazine | 39 | $1,535 | $39 |
| Cevimeline | 11 | $1,355 | $123 |
| Pilocarpine | 19 | $1,046 | $55 |
| Hydrocodone-Acetaminophen | 35 | $876 | $25 |
| Alendronate | 70 | $790 | $11 |
| Diclofenac | 24 | $679 | $28 |
| Allopurinol | 59 | $613 | $10 |
| Prednisone | 108 | $609 | $6 |
| Gabapentin | 47 | $563 | $12 |
| Ibuprofen | 30 | $269 | $9 |
| Naproxen | 19 | $142 | $7 |
| Nystatin | 11 | $44 | $4 |
| Tramadol | 12 | $43 | $4 |
| Meloxicam | 11 | $1 | $0 |
Year by year
| 2024 | 1,367 | 193 | 4% (50) | 37% | $2,899,145 |
| 2023 | 1,232 | 201 | 5% (58) | None | $2,772,896 |
| 2022 | 1,303 | 200 | 4% (57) | 37% | $2,451,313 |
| 2021 | 1,250 | 203 | 5% (58) | 36% | $2,212,419 |
| 2020 | 1,637 | 219 | 5% (82) | None | $2,230,013 |
| 2019 | 1,572 | 252 | 13% (200) | 33% | $1,766,111 |
| 2018 | 1,204 | 221 | 15% (176) | 28% | $856,400 |
| 2017 | 1,192 | 203 | 17% (197) | 26% | $788,953 |
| 2016 | 1,025 | 206 | 21% (211) | 25% | $537,314 |
| 2015 | 890 | 174 | 25% (222) | 24% | $328,351 |
| 2014 | 826 | 158 | 22% (178) | 21% | $225,461 |
| 2013 | 999 | 181 | 31% (311) | 20% | $201,386 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 35 drugs
| Humira | 57 | $393,243 | $6,899 |
| Enbrel Sureclick | 55 | $387,007 | $7,036 |
| Xeljanz | 52 | $350,670 | $6,744 |
| Humira | 45 | $328,708 | $7,305 |
| Humira(Cf) | 14 | $157,006 | $11,215 |
| Cosentyx Sensoready | 15 | $135,547 | $9,036 |
| Enbrel | 19 | $129,069 | $6,793 |
| Xeljanz Xr | 15 | $122,941 | $8,196 |
| Enbrel Mini | 16 | $121,814 | $7,613 |
| Cosentyx Sensoready (2 Pens) | 16 | $107,766 | $6,735 |
| Humira(Cf) | 11 | $84,531 | $7,685 |
| Orencia Clickject | 16 | $81,277 | $5,080 |
| Simponi | 12 | $71,109 | $5,926 |
| Otezla | 13 | $64,592 | $4,969 |
| Mitigare | 22 | $9,671 | $440 |
| Febuxostat | 32 | $7,703 | $241 |
| Methotrexate | 78 | $6,521 | $84 |
| Colchicine | 34 | $4,624 | $136 |
| Leflunomide | 44 | $4,371 | $99 |
| Mycophenolate Mofetil | 16 | $3,055 | $191 |
| Hydroxychloroquine Sulfate | 45 | $2,729 | $61 |
| Diclofenac | 56 | $2,390 | $43 |
| Sulfasalazine | 43 | $2,106 | $49 |
| Gabapentin | 43 | $1,428 | $33 |
| Pilocarpine | 12 | $1,248 | $104 |
| Allopurinol | 53 | $1,123 | $21 |
| Hydrocodone-Acetaminophen | 34 | $775 | $23 |
| Azathioprine | 22 | $701 | $32 |
| Alendronate | 38 | $547 | $14 |
| Omeprazole | 23 | $527 | $23 |
| Prednisone | 55 | $441 | $8 |
| Ibuprofen | 34 | $401 | $12 |
| Tramadol | 14 | $265 | $19 |
| Naproxen | 16 | $239 | $15 |
| Meloxicam | 14 | $63 | $4 |
2022: 30 drugs
| Enbrel Sureclick | 63 | $376,069 | $5,969 |
| Humira | 46 | $304,620 | $6,622 |
| Enbrel | 39 | $258,758 | $6,635 |
| Xeljanz | 49 | $258,424 | $5,274 |
| Humira | 43 | $254,183 | $5,911 |
| Orencia Clickject | 43 | $216,544 | $5,036 |
| Enbrel Mini | 25 | $174,111 | $6,964 |
| Humira(Cf) | 14 | $95,911 | $6,851 |
| Actemra Actpen | 12 | $55,610 | $4,634 |
| Orencia | 11 | $54,688 | $4,972 |
| Febuxostat | 48 | $17,533 | $365 |
| Mitigare | 38 | $12,033 | $317 |
| Colchicine | 22 | $11,178 | $508 |
| Methotrexate | 93 | $5,726 | $62 |
| Leflunomide | 32 | $4,385 | $137 |
| Hydroxychloroquine Sulfate | 78 | $3,993 | $51 |
| Pilocarpine | 41 | $3,266 | $80 |
| Sulfasalazine | 37 | $1,774 | $48 |
| Azathioprine | 19 | $1,415 | $74 |
| Gabapentin | 30 | $1,312 | $44 |
| Allopurinol | 53 | $1,289 | $24 |
| Diclofenac | 48 | $1,197 | $25 |
| Prednisone | 68 | $876 | $13 |
| Hydrocodone-Acetaminophen | 39 | $857 | $22 |
| Baclofen | 11 | $688 | $63 |
| Alendronate | 58 | $645 | $11 |
| Omeprazole | 34 | $502 | $15 |
| Ibuprofen | 39 | $372 | $10 |
| Tramadol | 13 | $261 | $20 |
| Naproxen | 16 | $124 | $8 |
2021: 33 drugs
| Enbrel Sureclick | 59 | $345,485 | $5,856 |
| Humira | 58 | $327,299 | $5,643 |
| Xeljanz | 54 | $265,879 | $4,924 |
| Enbrel | 42 | $248,585 | $5,919 |
| Humira | 32 | $190,300 | $5,947 |
| Humira(Cf) | 15 | $168,079 | $11,205 |
| Enbrel Mini | 26 | $163,000 | $6,269 |
| Orencia Clickject | 27 | $128,260 | $4,750 |
| Humira(Cf) | 11 | $69,726 | $6,339 |
| Orencia | 13 | $61,223 | $4,709 |
| Cosentyx Pen (2 Pens) | 12 | $57,521 | $4,793 |
| Actemra Actpen | 15 | $43,915 | $2,928 |
| Febuxostat | 27 | $14,447 | $535 |
| Mitigare | 34 | $12,780 | $376 |
| Colchicine | 23 | $9,463 | $411 |
| Methotrexate | 79 | $5,304 | $67 |
| Hydroxychloroquine Sulfate | 79 | $3,767 | $48 |
| Leflunomide | 27 | $3,180 | $118 |
| Pilocarpine | 39 | $3,070 | $79 |
| Sulfasalazine | 46 | $1,731 | $38 |
| Mycophenolate Mofetil | 14 | $1,440 | $103 |
| Allopurinol | 68 | $1,429 | $21 |
| Diclofenac | 39 | $1,287 | $33 |
| Azathioprine | 13 | $1,080 | $83 |
| Prednisone | 76 | $874 | $12 |
| Hydrocodone-Acetaminophen | 38 | $840 | $22 |
| Gabapentin | 32 | $678 | $21 |
| Alendronate | 54 | $671 | $12 |
| Nabumetone | 19 | $531 | $28 |
| Ibuprofen | 38 | $454 | $12 |
| Omeprazole | 20 | $246 | $12 |
| Naproxen | 20 | $172 | $9 |
| Tramadol | 11 | $64 | $6 |
2020: 36 drugs
| Xeljanz | 84 | $395,803 | $4,712 |
| Humira | 60 | $349,588 | $5,826 |
| Enbrel Sureclick | 60 | $325,757 | $5,429 |
| Orencia Clickject | 53 | $228,053 | $4,303 |
| Enbrel | 31 | $187,623 | $6,052 |
| Humira | 26 | $128,024 | $4,924 |
| Humira(Cf) | 11 | $126,464 | $11,497 |
| Enbrel Mini | 20 | $114,857 | $5,743 |
| Orencia | 15 | $68,190 | $4,546 |
| Simponi | 12 | $58,551 | $4,879 |
| Actemra Actpen | 13 | $51,036 | $3,926 |
| Cosentyx | 12 | $45,735 | $3,811 |
| Febuxostat | 31 | $13,943 | $450 |
| Colcrys | 34 | $13,236 | $389 |
| Mitigare | 26 | $10,285 | $396 |
| Hydroxychloroquine Sulfate | 141 | $7,516 | $53 |
| Colchicine | 25 | $6,662 | $266 |
| Methotrexate | 91 | $5,336 | $59 |
| Mycophenolate Mofetil | 23 | $4,242 | $184 |
| Leflunomide | 30 | $3,652 | $122 |
| Pilocarpine | 34 | $3,524 | $104 |
| Azathioprine | 24 | $2,986 | $124 |
| Sulfasalazine | 57 | $2,925 | $51 |
| Hydrocodone-Acetaminophen | 59 | $1,418 | $24 |
| Allopurinol | 90 | $1,226 | $14 |
| Prednisone | 105 | $1,076 | $10 |
| Gabapentin | 42 | $929 | $22 |
| Diclofenac | 31 | $802 | $26 |
| Alendronate | 65 | $656 | $10 |
| Ibuprofen | 48 | $516 | $11 |
| Nabumetone | 31 | $477 | $15 |
| Baclofen | 31 | $415 | $13 |
| Omeprazole | 51 | $269 | $5 |
| Naproxen | 12 | $104 | $9 |
| Triamcinolone Acetonide | 13 | $82 | $6 |
| Tramadol | 17 | $72 | $4 |
2019: 35 drugs
| Xeljanz | 75 | $333,889 | $4,452 |
| Humira | 52 | $294,528 | $5,664 |
| Enbrel | 38 | $202,459 | $5,328 |
| Orencia Clickject | 44 | $188,910 | $4,293 |
| Humira | 24 | $125,149 | $5,215 |
| Enbrel Sureclick | 23 | $110,306 | $4,796 |
| Cosentyx | 11 | $109,875 | $9,989 |
| Orencia | 17 | $72,073 | $4,240 |
| Uloric | 28 | $23,072 | $824 |
| Colcrys | 31 | $14,694 | $474 |
| Colchicine | 47 | $14,620 | $311 |
| Hydroxychloroquine Sulfate | 81 | $10,221 | $126 |
| Leflunomide | 32 | $8,371 | $262 |
| Pilocarpine | 49 | $6,054 | $124 |
| Methotrexate | 98 | $5,417 | $55 |
| Hydrocodone-Acetaminophen | 137 | $3,927 | $29 |
| Azathioprine | 29 | $2,854 | $98 |
| Mycophenolate Mofetil | 24 | $2,326 | $97 |
| Allopurinol | 89 | $2,072 | $23 |
| Sulfasalazine | 39 | $1,776 | $46 |
| Gabapentin | 45 | $1,277 | $28 |
| Prednisone | 99 | $1,254 | $13 |
| Voltaren | 15 | $832 | $55 |
| Ibandronate | 14 | $681 | $49 |
| Alendronate | 55 | $548 | $10 |
| Acetaminophen-Codeine | 21 | $412 | $20 |
| Baclofen | 29 | $407 | $14 |
| Tramadol | 42 | $374 | $9 |
| Ibuprofen | 45 | $350 | $8 |
| Nabumetone | 17 | $305 | $18 |
| Omeprazole | 40 | $237 | $6 |
| Naproxen | 16 | $177 | $11 |
| Triamcinolone Acetonide | 11 | $99 | $9 |
| Amlodipine Besylate | 11 | $96 | $9 |
| Meloxicam | 14 | $47 | $3 |
2018: 30 drugs
| Xeljanz | 43 | $189,054 | $4,397 |
| Enbrel | 29 | $171,951 | $5,929 |
| Humira | 32 | $154,071 | $4,815 |
| Humira | 27 | $134,191 | $4,970 |
| Simponi | 12 | $52,661 | $4,388 |
| Colcrys | 35 | $17,383 | $497 |
| Uloric | 17 | $15,431 | $908 |
| Hydroxychloroquine Sulfate | 81 | $10,449 | $129 |
| Pilocarpine | 60 | $7,771 | $130 |
| Leflunomide | 27 | $7,122 | $264 |
| Colchicine | 20 | $7,083 | $354 |
| Methotrexate | 92 | $6,894 | $75 |
| Hydrocodone-Acetaminophen | 113 | $3,683 | $33 |
| Azathioprine | 29 | $1,973 | $68 |
| Sulfasalazine | 54 | $1,868 | $35 |
| Allopurinol | 62 | $1,614 | $26 |
| Voltaren | 22 | $1,409 | $64 |
| Gabapentin | 45 | $928 | $21 |
| Mycophenolate Mofetil | 16 | $894 | $56 |
| Prednisone | 58 | $660 | $11 |
| Acetaminophen-Codeine | 28 | $568 | $20 |
| Tramadol | 33 | $390 | $12 |
| Ibuprofen | 41 | $343 | $8 |
| Naproxen | 15 | $288 | $19 |
| Baclofen | 12 | $236 | $20 |
| Alendronate | 24 | $200 | $8 |
| Omeprazole | 38 | $197 | $5 |
| Amlodipine Besylate | 12 | $118 | $10 |
| Meloxicam | 11 | $58 | $5 |
| Hydrocortisone | 14 | $44 | $3 |
2017: 30 drugs
| Humira | 33 | $154,388 | $4,678 |
| Humira | 33 | $146,323 | $4,434 |
| Enbrel | 17 | $107,816 | $6,342 |
| Xeljanz | 20 | $83,565 | $4,178 |
| Simponi | 13 | $52,543 | $4,042 |
| Colcrys | 44 | $21,386 | $486 |
| Uloric | 22 | $19,760 | $898 |
| Hydroxychloroquine Sulfate | 89 | $15,859 | $178 |
| Colchicine | 35 | $10,600 | $303 |
| Methotrexate | 87 | $8,351 | $96 |
| Leflunomide | 21 | $6,200 | $295 |
| Hydrocodone-Acetaminophen | 116 | $3,814 | $33 |
| Pilocarpine | 26 | $2,876 | $111 |
| Allopurinol | 75 | $2,077 | $28 |
| Sulfasalazine | 41 | $2,028 | $49 |
| Azathioprine | 30 | $1,603 | $53 |
| Mycophenolate Mofetil | 22 | $1,103 | $50 |
| Voltaren | 18 | $1,047 | $58 |
| Acetaminophen-Codeine | 48 | $806 | $17 |
| Prednisone | 64 | $605 | $9 |
| Gabapentin | 40 | $571 | $14 |
| Baclofen | 22 | $412 | $19 |
| Diclofenac | 12 | $308 | $26 |
| Ibuprofen | 42 | $277 | $7 |
| Alendronate | 32 | $217 | $7 |
| Naproxen | 13 | $177 | $14 |
| Omeprazole | 24 | $154 | $6 |
| Tramadol | 30 | $120 | $4 |
| Meloxicam | 14 | $85 | $6 |
| Amlodipine Besylate | 11 | $74 | $7 |
2016: 28 drugs
| Humira | 38 | $158,922 | $4,182 |
| Humira | 22 | $108,157 | $4,916 |
| Enbrel | 19 | $104,324 | $5,491 |
| Simponi | 12 | $45,131 | $3,761 |
| Uloric | 19 | $16,339 | $860 |
| Colcrys | 25 | $11,873 | $475 |
| Colchicine | 43 | $10,577 | $246 |
| Hydroxychloroquine Sulfate | 49 | $9,907 | $202 |
| Methotrexate | 61 | $5,260 | $86 |
| Leflunomide | 17 | $4,765 | $280 |
| Hydrocodone-Acetaminophen | 117 | $4,332 | $37 |
| Azathioprine | 20 | $1,423 | $71 |
| Pilocarpine | 13 | $1,362 | $105 |
| Acetaminophen-Codeine | 80 | $1,345 | $17 |
| Allopurinol | 49 | $1,256 | $26 |
| Voltaren | 18 | $930 | $52 |
| Sulfasalazine | 21 | $831 | $40 |
| Gabapentin | 41 | $693 | $17 |
| Prednisone | 55 | $668 | $12 |
| Baclofen | 29 | $549 | $19 |
| Naproxen | 40 | $403 | $10 |
| Alendronate | 42 | $358 | $9 |
| Ibuprofen | 35 | $322 | $9 |
| Nabumetone | 11 | $289 | $26 |
| Cyclobenzaprine | 13 | $219 | $17 |
| Omeprazole | 12 | $124 | $10 |
| Lidocaine | 12 | $98 | $8 |
| Tramadol | 13 | $63 | $5 |
2015: 22 drugs
| Humira | 32 | $100,454 | $3,139 |
| Humira | 16 | $53,106 | $3,319 |
| Enbrel | 14 | $46,990 | $3,356 |
| Uloric | 27 | $19,784 | $733 |
| Hydroxychloroquine Sulfate | 67 | $11,729 | $175 |
| Colcrys | 34 | $10,587 | $311 |
| Leflunomide | 19 | $6,102 | $321 |
| Hydrocodone-Acetaminophen | 144 | $4,969 | $35 |
| Methotrexate | 53 | $4,209 | $79 |
| Gabapentin | 18 | $1,182 | $66 |
| Acetaminophen-Codeine | 52 | $987 | $19 |
| Sulfasalazine | 19 | $983 | $52 |
| Allopurinol | 33 | $808 | $24 |
| Prednisone | 30 | $649 | $22 |
| Azathioprine | 16 | $529 | $33 |
| Baclofen | 31 | $456 | $15 |
| Alendronate | 34 | $291 | $9 |
| Ibuprofen | 38 | $287 | $8 |
| Omeprazole | 20 | $275 | $14 |
| Naproxen | 24 | $252 | $11 |
| Tramadol | 19 | $128 | $7 |
| Amlodipine Besylate | 13 | $98 | $8 |
2014: 21 drugs
| Enbrel | 28 | $106,533 | $3,805 |
| Humira | 21 | $64,638 | $3,078 |
| Uloric | 28 | $18,395 | $657 |
| Colcrys | 36 | $11,616 | $323 |
| Methotrexate | 40 | $5,080 | $127 |
| Hydrocodone-Acetaminophen | 128 | $3,043 | $24 |
| Gabapentin | 43 | $2,121 | $49 |
| Hydroxychloroquine Sulfate | 62 | $1,781 | $29 |
| Sulfasalazine | 35 | $1,602 | $46 |
| Leflunomide | 11 | $966 | $88 |
| Prednisone | 44 | $727 | $17 |
| Alendronate | 64 | $612 | $10 |
| Acetaminophen-Codeine | 37 | $535 | $14 |
| Baclofen | 20 | $405 | $20 |
| Nabumetone | 12 | $363 | $30 |
| Diclofenac | 14 | $362 | $26 |
| Omeprazole | 22 | $314 | $14 |
| Allopurinol | 23 | $294 | $13 |
| Naproxen | 20 | $257 | $13 |
| Ibuprofen | 27 | $239 | $9 |
| Tramadol | 12 | $105 | $9 |
2013: 19 drugs
| Humira | 39 | $89,966 | $2,307 |
| Enbrel | 23 | $62,344 | $2,711 |
| Uloric | 28 | $14,043 | $502 |
| Colcrys | 27 | $6,041 | $224 |
| Methotrexate | 36 | $4,575 | $127 |
| Hydrocodone-Acetaminophen | 226 | $4,495 | $20 |
| Sulfasalazine | 37 | $1,591 | $43 |
| Hydroxychloroquine Sulfate | 68 | $1,576 | $23 |
| Omeprazole | 34 | $931 | $27 |
| Acetaminophen-Codeine | 64 | $853 | $13 |
| Gabapentin | 50 | $846 | $17 |
| Prednisone | 54 | $699 | $13 |
| Alendronate | 47 | $694 | $15 |
| Diclofenac | 12 | $566 | $47 |
| Naproxen | 38 | $424 | $11 |
| Baclofen | 31 | $309 | $10 |
| Tramadol | 21 | $235 | $11 |
| Ibuprofen | 26 | $219 | $8 |
| Hydrochlorothiazide | 12 | $61 | $5 |
Money from drug and device companies
$93 in 2019
A payment is not proof that care is biased.
| Celgene | Otezla | $93 | 1 payment
|
See the published payment
| Celgene | Meals · 2019-11-11 | Otezla | $93 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1093841876
- Licence
- CA A88610California A88610: Current · expires 2028-01-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 260 Santa Monica Ave, Menlo Park, CA, 94025
- NPI first listed
- 2007-02-26
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.